To compare the safety and efficacy of paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), and their combinations in post-operative pain management.
The NSAIDs studied included: oral aspirin (650 mg); diclofenac as a suppository (12.5 to 100 mg) or oral dose (2 to 3 mg/kg, and 100 mg); naproxen as a suppository (1,000 mg) or oral dose (440 to 500 mg); ketorolac as an intravenous (30 mg) or oral (5 to 20 mg, and 1 mg/kg) dose; ibuprofen as oral (200 to 800 mg) or sustained release (1,600 mg and 10 mg/kg) dose; oral bromfenac (5 to 25 mg); oral ketoprofen (12.5 to 200 mg); oral tenoxicam (0.5 mg/kg and 40 mg); oral meclofenamate (100 to 200 mg); oral flurbiprofen (50 mg) oral difusinal (500 mg); and oral indoprofen (800 mg). Paracetamol was administered in suppository form (1,300 to 4,000 mg and 35 mg/kg), as an oral dose (500 to 8,000 mg, and 10 to 35 mg/kg), and as proparacetamol (2,000 mg intravenously). The drugs were given as a single pre-emptive dose, as a single post-operative dose, and on up to 7 consecutive days.
Participants included in the review
Th inclusion criteria were not defined in terms of the participants. The patients included adults and children who had undergone one of the following surgical procedures: major surgery, including abdominal and gynaecological surgery; orthopaedic surgery; gynaecological surgery including episiotomy and tubal ligation; ear, nose and throat surgery; and dental surgery.
Outcomes assessed in the review
Studies that assessed post-operative pain were eligible. Analgesic efficacy was assessed by standard pain measures, through quality of sleep, and through consumption of opioids or rescue analgesia. The standard pain measures included visual analogue scales, a variety of scoring systems, and objective and behavioural scores.
How were decisions on the relevance of primary studies made?
7 RCTs showed that combinations of paracetamol with NSAIDs (aspirin, ketoprofen and diclofenac) were associated with lower pain scores than paracetamol alone; 2 RCTs involving gynaecological surgery showed no differences between the treatment groups; and in one study, the pain scores were not measured. Five of the 7 RCTs showed significant reductions in opioid consumption for combinations of drugs when compared with paracetamol alone; and one RCT showed no difference between the treatment groups.
Paracetamol plus NSAIDs versus NSAIDs (4 RCTs, 190 patients): one of the 4 RCTs showed a reduction in pain scores at rest and on movement for the combination of paracetamol and ketoprofen, compared with ketoprofen alone; one RCT showed diclofenac plus paracetamol reduced pain after dental surgery in comparison with diclofenac alone; and 2 RCTs showed no difference between the treatment groups.
Adverse effects.
Relatively few studies compared the adverse effects of NSAIDs with paracetamol. Adverse reactions that have been reported in the literature were discussed. These related to gastrointestinal hepatic, renal and haematological effects, allergic reactions and miscellaneous. The latter included heterotopic bone formation, sleep disturbance, modification of body temperature, and drug interactions.
